BIOCRYST PHARMACEUTICALS INC Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 3.26 | 9,378 | 30,572 | 0 | |
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 3.26 | 20,622 | 67,228 | 0 | |
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.18 | 5,902 | 30,572 | 108,871 | 114.8 K to 108.9 K (-5.14 %) |
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 3.26 | 9,378 | 30,572 | 114,773 | 105.4 K to 114.8 K (+8.90 %) |
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.18 | 15,223 | 78,855 | 105,395 | 120.6 K to 105.4 K (-12.62 %) |
Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 3.26 | 20,622 | 67,228 | 120,618 | 100 K to 120.6 K (+20.62 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 3.26 | 56,949 | 185,654 | 0 | |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Payment of Exercise | F | 4.97 | 43,224 | 214,823 | 655,092 | 698.3 K to 655.1 K (-6.19 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 3.26 | 56,949 | 185,654 | 698,316 | 641.4 K to 698.3 K (+8.88 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 3.26 | 6,709 | 21,871 | 0 | |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 3.26 | 6,709 | 21,871 | 85,768 | 79.1 K to 85.8 K (+8.49 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | INGRAM ROBERT ALEXANDER | Director | Grant | A | 4.97 | 3,772 | 18,747 | 18,902 | 15.1 K to 18.9 K (+24.93 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.97 | 2,012 | 10,000 | 38,147 | 36.1 K to 38.1 K (+5.57 %) |